Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
ETFs
Etats-Unis
AMEX
Invesco Biotechnology and Genome ETF (PBE)
Invesco Biotechnology and Genome ETF (PBE) Options

Invesco Biotechnology and Genome ETF (PBE)

83,4781

-0,7019

(-0,83%)

Fermé 06 Juin 10:00PM

83,34

-0,1381

(-0,17%)

Après les heures de négociation: 1:59AM

Invesco Biotechnology and Genome ETF ([symbol]) Options

PBE Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
73,00	9,20	12,10	0,00	10,65	0,00	0,00 %	0	0	-
74,00	8,20	11,10	0,00	9,65	0,00	0,00 %	0	0	-
75,00	7,20	10,10	7,70	8,65	0,00	0,00 %	0	0	-
76,00	6,30	9,20	0,00	7,75	0,00	0,00 %	0	0	-
77,00	5,30	8,20	0,00	6,75	0,00	0,00 %	0	0	-
78,00	4,40	7,30	0,00	5,85	0,00	0,00 %	0	0	-
79,00	3,50	6,40	0,00	4,95	0,00	0,00 %	0	0	-
80,00	2,65	5,50	0,00	4,075	0,00	0,00 %	0	0	-
81,00	1,85	4,60	0,00	3,225	0,00	0,00 %	0	0	-
82,00	1,10	3,80	6,43	2,45	0,00	0,00 %	0	2	-
83,00	0,60	2,95	2,86	1,775	0,00	0,00 %	0	2	-
84,00	0,05	2,40	0,00	1,225	0,00	0,00 %	0	0	-
85,00	0,05	2,00	0,00	1,025	0,00	0,00 %	0	0	-
86,00	0,15	1,70	0,00	0,925	0,00	0,00 %	0	0	-
87,00	0,00	1,50	0,00	0,00	0,00	0,00 %	0	0	-
88,00	0,15	1,40	2,20	0,775	0,00	0,00 %	0	0	-
90,00	0,00	1,25	0,00	0,00	0,00	0,00 %	0	0	-
95,00	0,00	1,15	0,00	0,00	0,00	0,00 %	0	0	-
100,00	0,00	1,15	0,00	0,00	0,00	0,00 %	0	0	-
105,00	0,00	1,15	0,00	0,00	0,00	0,00 %	0	0	-

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
73,00	0,00	1,20	0,00	0,00	0,00	0,00 %	0	0	-
74,00	0,00	1,20	0,00	0,00	0,00	0,00 %	0	0	-
75,00	0,00	1,25	0,00	0,00	0,00	0,00 %	0	0	-
76,00	0,00	1,30	0,00	0,00	0,00	0,00 %	0	0	-
77,00	0,00	1,35	0,00	0,00	0,00	0,00 %	0	0	-
78,00	0,00	1,40	0,00	0,00	0,00	0,00 %	0	0	-
79,00	0,00	1,50	0,00	0,00	0,00	0,00 %	0	0	-
80,00	0,00	1,65	0,00	0,00	0,00	0,00 %	0	0	-
81,00	0,00	1,80	0,00	0,00	0,00	0,00 %	0	0	-
82,00	0,00	2,05	0,00	0,00	0,00	0,00 %	0	0	-
83,00	0,05	2,35	0,00	1,20	0,00	0,00 %	0	0	-
84,00	0,50	2,85	0,00	1,675	0,00	0,00 %	0	0	-
85,00	0,90	3,60	0,00	2,25	0,00	0,00 %	0	0	-
86,00	1,60	4,40	0,00	3,00	0,00	0,00 %	0	0	-
87,00	2,40	5,20	0,00	3,80	0,00	0,00 %	0	0	-
88,00	3,30	6,10	0,00	4,70	0,00	0,00 %	0	0	-
90,00	5,10	8,00	0,00	6,55	0,00	0,00 %	0	0	-
95,00	10,00	13,00	0,00	11,50	0,00	0,00 %	0	0	-
100,00	15,00	18,00	0,00	16,50	0,00	0,00 %	0	0	-
105,00	20,00	23,00	0,00	21,50	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCAGScage Future	US$ 0,8489 (196,61%)	92,75M
SPHLSpringview Holdings Ltd	US$ 5,38 (125,20%)	40,61M
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M
STISolidion Technology Inc	US$ 35,50 (56,32%)	38,55M
NUWENewellis Inc	US$ 0,1625 (-62,30%)	50M
NYXHNyxoah SA	US$ 1,41 (-51,04%)	2,47M
CYPHCypherpunk Technologies Inc	US$ 0,5176 (-47,26%)	30,53M
TDICDreamland Ltd	US$ 0,2277 (-37,68%)	12,09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3,91 (-36,73%)	381,9k
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
SNBRSleep Number Corporation	US$ 0,477 (36,25%)	305,13M
SMTKSmartKem Inc	US$ 0,419101 (30,97%)	232,19M
NVDANVIDIA Corporation	US$ 205,10 (-6,20%)	220,65M
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M

Monksdream

Monksdream il y a 3 minutes

NVDA! a interest rate fear hits big tech stocks
https://investorshub.advfn.com/uimage/uploads/2026/6/6/wfbnbIMG_2174.png

crazy horse 0

crazy horse 0 il y a 3 minutes

Wertheim & CO delivers high-quality advisory solutions tailored to premier privately held middle-market businesses and private investment firms.

Discreet and confidential transactions handled through private negotiations.

Full-spectrum M&A ad

ihorchu

ihorchu il y a 4 minutes

catsu1

catsu1 il y a 5 minutes

WHAT'S YOUR SOURCE

William777

William777 il y a 6 minutes

Five year subchapter 5 plan for Nutranomics INC. - 2026 is our year.

US Market News

US Market News il y a 8 minutes

Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®June 6, 2026 4:45 PM
Business Wire New data from CATALYST and MOMENTUM trials presented

HGiLS

HGiLS il y a 8 minutes

Nasrat would not have delayed if he was not sure we can do it and get paragraph 4 first to file.

He delivers.

tdbowieknife

tdbowieknife il y a 8 minutes

Here ya go...

Memorandum:

https://drive.google.com/file/d/1ur0tbW0KGZv4LJm4p2GHG5uJGQQqOnTN/view?usp=sharing

Declaration:

https://drive.google.com/file/d/1LoHKsClX1RIQn3ymAbx_qr1mNUwMVPSc/view

I haven't read them yet. Up Nor

lakers17

lakers17 il y a 9 minutes

This one has been a total POS. I finally dumped it awhile ago before that 1 for 2500 reverse split. Of course they will dilute again. Will never be anything and was just a stinky OTC trip pinky that burned all previous shareholders.

CarlinNM

CarlinNM il y a 9 minutes

I'd be stunned if there were an acquisition announcement this year and I certainly don't oppose a buyout at some point in the distant future. Part of my concern is my cost basis and selling price, as I'm not one of the fortunate investors who owns this at a sub-$1 value. If an acquisition happens

dewophile

dewophile il y a 10 minutes

“ABT is now beset by (spurious, IMO) litigation on multiple fronts in its nutrition business”
Gives me pause too but a pretty close to worst case scenario may be priced in already but I can’t really be sure. Bayer is the poster child for the worst case scenario and they may be getting good ne

quester614

quester614 il y a 11 minutes

If you don't think MMs manipulate OTC prices I can see why you think Nexboard is real. That's why they are called Market MAKERS. Do you think this run of 350% wasn't due to the note holders and the MM manipulating the price. Just like any of the groups that follow their leader they run the volume an

FanOfspringsteen

FanOfspringsteen il y a 20 minutes

My3sons,, it's not the first time they're posting negative articles. As you said, it's more a matter of pattern of analysis that biased the result.

skitahoe

skitahoe il y a 20 minutes

I've left little doubt that my position in NWBO is concentrated, it became more so with AVXL's failure to get European approval, nearly all my position there has been eliminated. If I'm right my kids will be set for life, if not we'll still be sitting on a couple million in real estate equity.

PowerPlay1

PowerPlay1 il y a 24 minutes

$BIEI $BYND Put on radar!!

Smartypants2

Smartypants2 il y a 24 minutes

They are obviously focusing on certification. That will address every issue, including revenue, PPS, and getting back on the QB.

Lewrock

Lewrock il y a 24 minutes

I go long term on a lot of shares over the next few weeks. Then a bunch more in December. It feels good to cross over to the lower tax bracket. I see very little risk of being bought out in 2026.

1plus1

1plus1 il y a 27 minutes

TAT .... THAT WOULD BE A GREAT IDEA . WITH PINKY ANYTHING IS POSSIBLE

Chartmaster

Chartmaster il y a 28 minutes

Disagree as usual, and no one's shorting OTC unless they have $2.50 a share margin requirement, duh!

DeerBalls

DeerBalls il y a 28 minutes

$.0089 Hey, waggy, please pick up milk while you're out, and some prunes! Some have said I'm full of it! 🤣

Many times when developments are stung out/delayed, or take longer than expected, they are BIG DEVELOPMENTS! This is the case now; been rumors of something for a fe

snupoled

snupoled il y a 29 minutes

Sorry wrong board
Snup

snupoled

snupoled il y a 30 minutes

Snup? Why so serious? Downcast?
Elite whoppers
Letter to the shareholders
Sequest approval just a labelling formality now
Mikah is mothballed
We will go to NASDAQ and trade over a dollar soon.
Stock was approximately trading where it was 10 years ago and eli

Chartmaster

Chartmaster il y a 31 minutes

Anything is possible in OTC

Chartmaster

Chartmaster il y a 32 minutes

Lol! OK, thanks for the correction! Lol!

Invesco Biotechnology an...

CD Private Equity Fund III

AmerisourceBergen

Overlay Shares Large Cap...

Scentre Group Trust 1 an...

Defiance Daily Target 2X...

Acacia Research Technolo...

Ascendant Digital Acquis...

Vontobel Financial Produ...

President Energy

Amundi Core USD Corporat...

Brookstone Active ETF

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.